ArticleCancer medicine2026
Clinical Implications of Nutritional Intake in Patients With Esophageal Squamous Cell Carcinoma Receiving Chemoradiotherapy and Neoadjuvant Chemotherapy.
Article in Cancer medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNutritional management plays a pivotal role in the treatment of esophageal squamous cell carcinoma (ESCC). However, the impact of nutritional intake on patients' nutritional status during treatment remains unclear.
methodsThis retrospective study aimed to compare the nutritional status of patients with ESCC with that of healthy controls and evaluate how nutritional intake affects patients undergoing chemoradiotherapy (CRT) and neoadjuvant chemotherapy (NAC). Clinical data from 166 patients with ESCC who received two courses of chemotherapy with 5-fluorouracil plus cisplatin (109 in the CRT group and 57 patients in the NAC group) were examined, along with 166 matched healthy controls.
resultsCompared with healthy controls, patients with ESCC had poorer nutritional status as assessed using serum albumin levels, body mass index (BMI), and psoas muscle mass index (PMI), which declined further during treatment. Notably, patients who achieved sufficient energy and protein intake maintained better nutritional status. Although no significant differences were observed in nutritional intake between the groups, the CRT group was associated with greater decreases in serum albumin levels, BMI, and PMI than the NAC group.
conclusionAdequate nutrition intake may mitigate the deterioration of the nutritional status in patients with ESCC during treatment. Moreover, nutritional requirements may differ depending on the treatment modality, such as CRT and NAC. These findings underscore the importance of individualized nutritional management in the care of patients with ESCC.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.